- Report
- April 2025
- 175 Pages
Global
From €3941EUR$4,490USD£3,429GBP
- Report
- April 2025
- 175 Pages
Global
From €3941EUR$4,490USD£3,429GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1317EUR$1,500USD£1,146GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1756EUR$2,000USD£1,527GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1097EUR$1,250USD£955GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1097EUR$1,250USD£955GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1756EUR$2,000USD£1,527GBP
- Drug Pipelines
- April 2025
- 50 Pages
Global
From €1317EUR$1,500USD£1,146GBP
- Report
- April 2025
- 182 Pages
Global
From €3950EUR$4,500USD£3,437GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1097EUR$1,250USD£955GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1317EUR$1,500USD£1,146GBP
- Report
- January 2026
- 185 Pages
Global
From €3950EUR$4,500USD£3,437GBP
- Report
- January 2026
- 180 Pages
Global
From €3950EUR$4,500USD£3,437GBP
- Report
- June 2025
- 150 Pages
Global
From €2369EUR$2,699USD£2,061GBP
- Report
- June 2025
- 200 Pages
Global
From €2448EUR$2,789USD£2,130GBP
- Report
- August 2025
- 150 Pages
Global
From €3379EUR$3,850USD£2,940GBP
€4257EUR$4,850USD£3,704GBP
- Report
- July 2025
- 150 Pages
Global
From €3379EUR$3,850USD£2,940GBP
€4257EUR$4,850USD£3,704GBP
- Report
- May 2025
- 134 Pages
Global
From €15796EUR$17,995USD£13,742GBP
- Report
- February 2026
- 50 Pages
Global
From €2326EUR$2,650USD£2,024GBP
- Report
- February 2026
- 50 Pages
Global
From €2326EUR$2,650USD£2,024GBP

The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus.
The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more